[1]阙娴婷,秦超,梁志坚,等.前列腺癌相关脑梗死的发病特点[J].卒中与神经疾病杂志,2018,25(02):155-158+162.[doi:10.3969/j.issn.1007-0478.2018.02.009]
　Que Xianting,Qin Chao,Liang Zhijian,et al.Clinical features of ischemic stroke in patients with prostate cancer[J].Stroke and Nervous Diseases,2018,25(02):155-158+162.[doi:10.3969/j.issn.1007-0478.2018.02.009]
点击复制

前列腺癌相关脑梗死的发病特点()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第25卷
期数:
2018年02期
页码:
155-158+162
栏目:
论 著
出版日期:
2018-04-26

文章信息/Info

Title:
Clinical features of ischemic stroke in patients with prostate cancer
文章编号:
1007-0478(2018)02-0155-05
作者:
阙娴婷; 秦超; 梁志坚; 李重霖; 陈莉; 程道宾; 颜海标; 邓添薪
530021 南宁,广西医科大学第一附属医院神经内科[阙娴婷 秦超 梁志坚(通信作者)李重霖 陈莉 程道宾],泌尿外科(颜海标),病案管理科(邓添薪)
Author(s):
Que Xianting; Qin Chao; Liang Zhijian; et al.
Department of Neurology,The First Affiliated Hospital of Guangxi Medical University,Nanning 530021
关键词:
前列腺癌 脑梗死 临床特点 发病机制
Keywords:
Prostate cancer Ischemic stroke Clinical feature Pathogenesis
分类号:
R743.3 R737.25
DOI:
10.3969/j.issn.1007-0478.2018.02.009
文献标志码:
A
摘要:
目的 探讨前列腺癌相关脑梗死的发病特点。方法 收集2003年1月-2015年12月在广西医科大学第一附属院住院治疗的前列腺癌合并脑梗死患者的临床表现、实验室及器械检查等资料。结果 本研究共筛查前列腺癌患者2 584例,其中符合前列腺癌合并脑梗死的患者共有34例(1.31%),平均年龄(61.60±6.28)岁。入选的患者中无脑卒中危险因素21例(61.76%)。血液学检查发现D-二聚体水平升高22例(64.71%),总前列腺特异性抗原(Total prostate specific antigen,T-PSA)水平异常升高(>100 ng/mL )19例(55.88%),头颅MRI显示脑内单一梗死灶8例(23.52%),出现累及多个动脉供血区的2个或2个以上梗死灶26例(76.47%),脑梗死发生30 d多数患者预后不良,其中4例(11.77%)死亡。结论 前列腺癌相关脑梗死的患者以缺少常见的脑卒中危险因素、血清D-二聚体水平升高以及T-PSA异常升高、一次发病出现累及多血管分布区的多发性梗死灶以及预后不良等为特点,其发生机制可能与患者血液的凝固性升高有关。
Abstract:
ObjectiveTo investigate the clinical features of ischemic stroke in patients with prostate cancer.Methods The clinical data of prostate cancer patients with acute ischemic stroke in first affiliated hospital of Guangxi medical university from January,2003 and December 2015 were retrospectively analyzed.Results Out of 2 584 cases of prostate cancer patients,34 patients were suffered from acute ischemic sroke(1.31%),with an average age of(61.60±6.28)years.Among the 34 patients,21 patients(61.76%)lacked of the conventional risk factors for ischemic stroke.Blood biochemistry tests showed that there was an elevated plasma D-dimer levels in 22 patients(64.71%)and there was a significantly elevated levels of the total prostate specific antigen in 19 patients(55.88%)(>100 ng/mL).And the magnetic resonance imaging examination showed that there was the single lesions in 8 patients(23.52%)and there were two or more lesions distributed to multiple cerebral arterial regions in the other 26 patients(76.47%).At the 30th day,most of the prostate cancer patients with acute ischemic stroke were found with poor prognosis,and 4 patients died.Conclusion It was suggested that the ischemic stroke associate to prostate cancer had distinct clincal feathers such as without the conventional risk factors,with an elevated plasma D-dimer levels and a significantly elevated levels of T-PSA,and with multiple lesions distributed to multiple cerebral arterial regions.And its pathogenesis might be related to blood hypercoagulability.

参考文献/References:

[1] Zöller B,Ji J,Sundquist J,et al.Risk of haemorrhagic and ischaemic stroke in patients with cancer:a nationwide follow-up study from Sweden[J].Eur J Cancer,2012,48(12):1875-1883.
[2] Chu CN,Chen PC,Bai LY,et al.Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischaemic risk of stroke:a National database,controlled cohort study[J].Clin Otolaryngol,2013,38(1):39-47.
[3] Guo YJ,Chang MH,Chen PL,et al.Predictive value of plasma(D)-dimer levels for cancer-related stroke:a 3-year retrospective study[J].J Stroke Cerebrovasc Dis,2014,23(4):e249-e254.
[4] Kim JM,Jung KH,Park KH,et al.Clinical manifestation of cancer related stroke:retrospective case-control study[J].J Neurooncol,2013,111(3):295-301.
[5] Schwarzbach CJ,Fatar M,Eisele P,et al.DWI lesion patterns in Cancer-Related Stroke--Specifying the phenotype[J].Cerebrovasc Dis Extra,2015,5(3):139-145.
[6] Stergiopoulos K,Vasu S,Bilfinger T,et al.Embolic stroke in a patient with metastatic renal cell cancer[J].Hellenic journal of cardiology:HJC,2011,52(3):256-258.
[7] Devulapalli S,Pinto N,Gandothra C,et al.A rare case of occipital stroke as a consequence of nonbacterial thrombotic endocarditis in ovarian clear cell carcinoma:a case report[J].Case Rep Neurol,2012,4(1):84-91.
[8] Kim K,Lee JH.Risk factors and biomarkers of ischemic stroke in cancer patients[J].Journal of stroke,2014,16(2):91-96.
[9] Dimitrovi('overc)A,Breitenfeld T,Supanc V,et al.Stroke caused by lung cancer invading the left atrium[J].J Stroke Cerebrovasc Dis,2016,25(5):e66-e68.
[10] Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
[11] Teoh JY,Chiu PK,Chan SY,et al.Risk of ischemic stroke after androgen deprivation therapy for prostate cancer in the Chinese population living in Hong Kong[J].Jpn J Clin Oncol,2015,45(5):483-487.
[12] Lee CW,Muo CH,Liang JA,et al.Association of intensive morphine treatment and increased stroke incidence in prostate cancer patients:a population-based nested case-control study[J].Jpn J Clin Oncol,2013,43(8):776-781.
[13] Heidenreich A,Bastian PJ,Bellmunt JA,et al.EAU guidelines on prostate cancer.part 1:screening,diagnosis,and local treatment with curative Intent-Update 2013[J].Eur Urol,2014,65(1):124-137.
[14] Jauch EC,Saver JL,Adams HP,et al.Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2013,44(3):870-947.
[15] Kwon HM,Kang BS,Yoon BW.Stroke as the first manifestation of concealed cancer[J].J Neurol Sci,2007,258(1/2):80-83.
[16] Park HY,Lee HS,Chang H,et al.Multifocal strokes as the initial manifestation of metastatic tumors[J].Neurologist,2010,16(5):322-324.
[17] Kim SJ,Park JH,Lee MJ,et al.Clues to occult cancer in patients with ischemic stroke[J].PLoS One,2012,7(9):e44959.
[18] Seok JM,Kim SG,Kim JW,et al.Coagulopathy and embolic signal in cancer patients with ischemic stroke[J].Ann Neurol,2010,68(2):213-219.
[19] Jovin TG,Boosupalli V,Zivkovic SA,et al.High titers of CA-125 May be associated with recurrent ischemic strokes in patients with cancer[J].Neurology,2005,64(11):1944-1945.
[20] Piazza G.Venous thromboembolism and cancer[J].Circulation,2013,128(24):2614-2618.
[21] Ay C,Posch F,Kaider A,et al.Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality[J].J Thromb Haemost,2015,13(3):390-397.
[22] Wharin C,Tagalakis V.Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants[J].Blood Rev,2014,28(1):1-8.
[23] Den Exter PL,Kooiman J,Van Der Hulle T,et al.New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism[J].Best Pract Res Clin Haematol,2013,26(2):163-169.
[24] Suenaga M,Mizunuma N,Shinozaki E,et al.Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab[J].Onco Targets Ther,2015,8:243-249.
[25] Graber JJ,Nayak L,Deangelis LM.Use of recombinant tissue plasminogen activator in cancer patients with acute stroke[J].J Neurooncol,2012,107(3):571-573.
[26] Murthy SB,Karanth S,Shah S,et al.Thrombolysis for acute ischemic stroke in patients with cancer:a population study[J].Stroke,2013,44(12):3573-3576.
[27] Yoneda Y,Fukuda A,Yamazaki T,et al.Intravenous tissue plasminogen activator for an ischemic stroke with occult double primary cancer[J].Case Rep Neurol,2014,6(3):238-242.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(30860088、81260186); 广西自然科学基金(0832134、0991149、2015GXNSFAA139228); 广西教育厅科研项目(200710LX060); 广西医科大学博士启动基金(304214)
更新日期/Last Update: 2018-04-20